Real-time electronic adherence monitoring is feasible, comparable to unannounced pill counts, and acceptable

Jessica E. Haberer, Gregory K. Robbins, Michele Ybarra, Alexandra Monk, Kathleen Ragland, Sheri D. Weiser, Mallory O. Johnson, David Bangsberg

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Second generation electronic medication adherence monitors provide real-time data on pill bottle opening behavior. Feasibility, validity, and acceptability, however, have not been established. Med-eMonitor is a multi-compartment adherence device with reminder and education capacity that transmits data through a telephone connection. Monthly adherence levels were measured for 52 participants over approximately 3 months using the Med-eMonitor (unadjusted and adjusted for participant confirmed dosing) and unannounced pill counts. HIV RNA was assessed before and after the 3-month period. Acceptability of Med-eMonitor was determined. Over 92% of Med-eMonitor data was transmitted daily. Unannounced pill counts significantly correlated with adjusted MedeMonitor adherence (r = 0.29, P = 0.04). HIV RNA significantly correlated with unannounced pill counts (r = -0.34, P = 0.02), and trended toward a significant correlation with unadjusted Med-eMonitor adherence (r = -0.26; P = 0.07). Most, but not all, participants liked using the Med-eMonitor. Med-eMonitor allows for realtime adherence monitoring and potentially intervention, which may be critical for prolonging treatment success.

Original languageEnglish (US)
Pages (from-to)375-382
Number of pages8
JournalAIDS and Behavior
Volume16
Issue number2
DOIs
StatePublished - Feb 2012
Externally publishedYes

Fingerprint

HIV
RNA
Medication Adherence
Telephone
Education
Equipment and Supplies

Keywords

  • HIV antiretroviral therapy
  • Real-time adherence monitoring

ASJC Scopus subject areas

  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • Social Psychology

Cite this

Real-time electronic adherence monitoring is feasible, comparable to unannounced pill counts, and acceptable. / Haberer, Jessica E.; Robbins, Gregory K.; Ybarra, Michele; Monk, Alexandra; Ragland, Kathleen; Weiser, Sheri D.; Johnson, Mallory O.; Bangsberg, David.

In: AIDS and Behavior, Vol. 16, No. 2, 02.2012, p. 375-382.

Research output: Contribution to journalArticle

Haberer, JE, Robbins, GK, Ybarra, M, Monk, A, Ragland, K, Weiser, SD, Johnson, MO & Bangsberg, D 2012, 'Real-time electronic adherence monitoring is feasible, comparable to unannounced pill counts, and acceptable', AIDS and Behavior, vol. 16, no. 2, pp. 375-382. https://doi.org/10.1007/s10461-011-9933-y
Haberer, Jessica E. ; Robbins, Gregory K. ; Ybarra, Michele ; Monk, Alexandra ; Ragland, Kathleen ; Weiser, Sheri D. ; Johnson, Mallory O. ; Bangsberg, David. / Real-time electronic adherence monitoring is feasible, comparable to unannounced pill counts, and acceptable. In: AIDS and Behavior. 2012 ; Vol. 16, No. 2. pp. 375-382.
@article{6fe5387e1c31432fa66b54552fd01dbe,
title = "Real-time electronic adherence monitoring is feasible, comparable to unannounced pill counts, and acceptable",
abstract = "Second generation electronic medication adherence monitors provide real-time data on pill bottle opening behavior. Feasibility, validity, and acceptability, however, have not been established. Med-eMonitor is a multi-compartment adherence device with reminder and education capacity that transmits data through a telephone connection. Monthly adherence levels were measured for 52 participants over approximately 3 months using the Med-eMonitor (unadjusted and adjusted for participant confirmed dosing) and unannounced pill counts. HIV RNA was assessed before and after the 3-month period. Acceptability of Med-eMonitor was determined. Over 92{\%} of Med-eMonitor data was transmitted daily. Unannounced pill counts significantly correlated with adjusted MedeMonitor adherence (r = 0.29, P = 0.04). HIV RNA significantly correlated with unannounced pill counts (r = -0.34, P = 0.02), and trended toward a significant correlation with unadjusted Med-eMonitor adherence (r = -0.26; P = 0.07). Most, but not all, participants liked using the Med-eMonitor. Med-eMonitor allows for realtime adherence monitoring and potentially intervention, which may be critical for prolonging treatment success.",
keywords = "HIV antiretroviral therapy, Real-time adherence monitoring",
author = "Haberer, {Jessica E.} and Robbins, {Gregory K.} and Michele Ybarra and Alexandra Monk and Kathleen Ragland and Weiser, {Sheri D.} and Johnson, {Mallory O.} and David Bangsberg",
year = "2012",
month = "2",
doi = "10.1007/s10461-011-9933-y",
language = "English (US)",
volume = "16",
pages = "375--382",
journal = "AIDS and Behavior",
issn = "1090-7165",
publisher = "Springer New York",
number = "2",

}

TY - JOUR

T1 - Real-time electronic adherence monitoring is feasible, comparable to unannounced pill counts, and acceptable

AU - Haberer, Jessica E.

AU - Robbins, Gregory K.

AU - Ybarra, Michele

AU - Monk, Alexandra

AU - Ragland, Kathleen

AU - Weiser, Sheri D.

AU - Johnson, Mallory O.

AU - Bangsberg, David

PY - 2012/2

Y1 - 2012/2

N2 - Second generation electronic medication adherence monitors provide real-time data on pill bottle opening behavior. Feasibility, validity, and acceptability, however, have not been established. Med-eMonitor is a multi-compartment adherence device with reminder and education capacity that transmits data through a telephone connection. Monthly adherence levels were measured for 52 participants over approximately 3 months using the Med-eMonitor (unadjusted and adjusted for participant confirmed dosing) and unannounced pill counts. HIV RNA was assessed before and after the 3-month period. Acceptability of Med-eMonitor was determined. Over 92% of Med-eMonitor data was transmitted daily. Unannounced pill counts significantly correlated with adjusted MedeMonitor adherence (r = 0.29, P = 0.04). HIV RNA significantly correlated with unannounced pill counts (r = -0.34, P = 0.02), and trended toward a significant correlation with unadjusted Med-eMonitor adherence (r = -0.26; P = 0.07). Most, but not all, participants liked using the Med-eMonitor. Med-eMonitor allows for realtime adherence monitoring and potentially intervention, which may be critical for prolonging treatment success.

AB - Second generation electronic medication adherence monitors provide real-time data on pill bottle opening behavior. Feasibility, validity, and acceptability, however, have not been established. Med-eMonitor is a multi-compartment adherence device with reminder and education capacity that transmits data through a telephone connection. Monthly adherence levels were measured for 52 participants over approximately 3 months using the Med-eMonitor (unadjusted and adjusted for participant confirmed dosing) and unannounced pill counts. HIV RNA was assessed before and after the 3-month period. Acceptability of Med-eMonitor was determined. Over 92% of Med-eMonitor data was transmitted daily. Unannounced pill counts significantly correlated with adjusted MedeMonitor adherence (r = 0.29, P = 0.04). HIV RNA significantly correlated with unannounced pill counts (r = -0.34, P = 0.02), and trended toward a significant correlation with unadjusted Med-eMonitor adherence (r = -0.26; P = 0.07). Most, but not all, participants liked using the Med-eMonitor. Med-eMonitor allows for realtime adherence monitoring and potentially intervention, which may be critical for prolonging treatment success.

KW - HIV antiretroviral therapy

KW - Real-time adherence monitoring

UR - http://www.scopus.com/inward/record.url?scp=84859708486&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859708486&partnerID=8YFLogxK

U2 - 10.1007/s10461-011-9933-y

DO - 10.1007/s10461-011-9933-y

M3 - Article

C2 - 21448728

AN - SCOPUS:84859708486

VL - 16

SP - 375

EP - 382

JO - AIDS and Behavior

JF - AIDS and Behavior

SN - 1090-7165

IS - 2

ER -